Lee’s Pharmaceutical Holdings Limited (HK:0950) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Lee’s Pharmaceutical Holdings Limited has announced the issuance of 1,764,000 share options under its Share Option Scheme on June 20, 2024, with an exercise price set at HK$1.200 per share. The options, which have a market value of around HK$2.116 million based on the current share price, will have a vesting period extending from June 2025 to December 2025 and are exercisable until June 2034.
For further insights into HK:0950 stock, check out TipRanks’ Stock Analysis page.